Synthesis and Pharmacological Evaluation of (+)-Usnic Acid Derivatives as Hypoglycemic Agents

Synthesis and Pharmacological Evaluation of (+)-Usnic Acid Derivatives as Hypoglycemic Agents Full article

Journal

MolBank
ISSN: 1422-8599

Output data

Year: 2022, Volume: 2022, Number: 4, Pages: M1459 Pages count : DOI: 10.3390/m1459

Tags

usnic acid; enamines; hypoglycemic action; diabetes mellitus

Authors

Borisov Sergey A. ¹ , Luzina Olga A. ¹ , Khvostov Mikhail V. ¹ , Tolstikova Tatiana G. ¹ , Salakhutdinov Nariman F. ¹

Affiliations

1	N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry of Siberian Branch of Russian Academy of Sciences

Usnic acid is produced by lichens and exhibits different biological properties, including hypoglycemic ones. However, this effect becomes noticeable only at relatively high doses, something that may lead to some adverse effects. The chemical modification of the molecule is able to enhance its safety profile and its hypoglycemic properties. We synthesized six enamine derivatives of (+)-usnic acid, and two of them are novel. All compounds were evaluated for the hypoglycemic effect after oral introduction in mice with alloxan-induced diabetes mellitus at a dose of 50 mg/kg. The derivative containing a 4-trifluoromethylphenyl fragment showed the most pronounced hypoglycemic effect, which was detected starting from sixth day of the experiment. Also, OGTT was performed in mice without alteration of glucose metabolism (C57BL/6), which showed no hypoglycemic effect after oral introduction of all studied compounds.

Borisov S.A. , Luzina O.A. , Khvostov M.V. , Tolstikova T.G. , Salakhutdinov N.F.
Synthesis and Pharmacological Evaluation of (+)-Usnic Acid Derivatives as Hypoglycemic Agents
MolBank. 2022. V.2022. N4. P.M1459. DOI: 10.3390/m1459 WOS РИНЦ

Submitted:	Sep 8, 2022
Accepted:	Oct 1, 2022
Published online:	Oct 8, 2022

Web of science	WOS:000902779000001
Elibrary	56823533
OpenAlex	W4303856575